The Prognostic Significance of the Serum Biomarker Heart-Fatty Acidic Binding Protein in Comparison with S100b in Severe Traumatic Brain Injury
- 1 October 2013
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 30 (19) , 1631-1637
Abstract
The outcome after severe traumatic brain injury (TBI) is largely unfavorable, with approximately two thirds of patients suffering from severe disabilities or dying during the first 6 months. Existing predictive models displayed only limited utility for outcome prediction in individual patients. Time courses of heart-fatty acidic binding protein (H-FABP) and their association with outcome were investigated and compared with S100b. Forty-nine consecutive patients with severe TBI (sTBI; Head component of the Abbreviated Injury Scale [HAIS] >3) with mono and multiple trauma were enrolled in this study. Enzyme-linked immunosorbent assay measured blood concentrations of H-FABP and S100b at 6, 12, 24, and 48 h after TBI. Outcome measures were conscious state at 14 days (Glasgow Coma Scale), disability (Glasgow Outcome Scale Extended; GOSE), and mortality at 3 months. Univariate logistic regression analysis and receiver operating characteristic curves analysis were carried out. Maximal H-FABP and S100b concentrations were observed at 6 h after TBI (34.4±34.0 and 0.64±0.99 ng/mL, respectively). Patients with multi-trauma had significantly higher H-FABP concentrations at 24 and 48 h (22.6±25.6 and 12.4±18.2 ng/mL, respectively), compared to patients with mono trauma (6.9±5.1 and 3.7±4.2 ng/mL, respectively). In the first 48 h, H-FABP and S100b were inversely correlated with the GOSE at 3 months; H-FABP at 48 h predicted mortality with 75% sensitivity and 93% specificity. Early blood levels of H-FABP after sTBI have prognostic significance for survival and disability.Keywords
This publication has 39 references indexed in Scilit:
- Predicting 14-Day Mortality after Severe Traumatic Brain Injury: Application of the IMPACT Models in the Brain Trauma Foundation TBI-trac ® New York State DatabaseJournal of Neurotrauma, 2012
- Glial Neuronal Ratio: A Novel Index for Differentiating Injury Type in Patients with Severe Traumatic Brain InjuryJournal of Neurotrauma, 2012
- Use of Serum Biomarkers to Predict Cerebral Hypoxia after Severe Traumatic Brain InjuryJournal of Neurotrauma, 2012
- The economic cost of brain disorders in EuropeEuropean Journal of Neurology, 2011
- Epidemiology, Severity Classification, and Outcome of Moderate and Severe Traumatic Brain Injury: A Prospective Multicenter StudyJournal of Neurotrauma, 2011
- Neuron-Specific Enolase, S100B, and Glial Fibrillary Acidic Protein Levels as Outcome Predictors in Patients With Severe Traumatic Brain InjuryNeurosurgery, 2011
- The use of Glasgow Coma Scale in injury assessment: A critical reviewBrain Injury, 2009
- How many people return to work after acquired brain injury?: A systematic reviewBrain Injury, 2009
- Epidemiology of Severe Brain Injuries: A Prospective Population-Based Study2001
- The European Brain Injury Consortium Survey of Head InjuriesActa Neurochirurgica, 1999